VTU Technology, Minapharm sign rHSA licensing deal
Pursuant to the deal, Minapharm will leverage VTU´s Pichia pastoris protein expression technology in rHSA production and VTU will contribute expression strain development and bioprocess optimization process for
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.